Related Experiment Video

Updated: May 10, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Immune alterations and immunotherapy prospects in head and neck cancer

Vincent Varilla1, Jonessa Atienza, Constantin A Dasanu

  • 1University of Connecticut Medical Center, Department of Internal Medicine, Hartford, CT 06106, USA. vvarilla@resident.uchc.edu

Expert Opinion on Biological Therapy
|June 25, 2013
PubMed
Abstract

Insights

Head and neck squamous cell carcinoma (HNSCC) involves immune defects. Immunotherapy offers a promising alternative to traditional treatments, potentially reducing side effects and improving long-term outcomes for HNSCC patients.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Head and neck squamous cell carcinoma (HNSCC) is associated with significant immune cell and cytokine abnormalities.
  • Current HNSCC therapies have limited success and severe side effects, necessitating novel treatment approaches.

Purpose of the Study:

  • To review immune system alterations in HNSCC.
  • To explore the rationale for experimental immunotherapies in HNSCC management.

Main Methods:

  • Comprehensive literature review using PubMed.
  • Analysis of ongoing clinical trials for HNSCC immunotherapy agents via clinicaltrials.gov.

Main Results:

  • Patients with HNSCC exhibit T-cell dysfunction, altered cytokines, and impaired antigen presentation.
  • The tumor microenvironment plays a crucial role in HNSCC progression.

Conclusions:

  • Immunotherapy is a growing area of interest for HNSCC treatment due to its potential to avoid toxic side effects and induce immunologic memory.
  • Promising immunotherapy strategies include nonspecific immune stimulation, targeting tumor antigens, and therapeutic vaccines.
  • These novel approaches may enhance future treatment options for HNSCC.

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...